Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Total Debt

Short-term and long-term borrowings combined.

Koninklijke Philips N.V.NYSE: PHG

Total Debt · Q2 FY2026 · quarter ended Jun 2026

Total debt falls 11.4% from a year ago

Total debt stood at €7.47B at the end of Q2 FY2026, down 11.4% from a year earlier and down 7.9% from the prior quarter. Over 3 fiscal years it compounded at +3.3% a year.

Context

  • Total debt amounted to 28.0% of total assets at the end of Q2 FY2026, down 4.0 pp from a year earlier.
  • Total debt increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -11.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
€7.47B-7.9% QoQ
Last fiscal yearDec 2025
€8.09B+7.9% YoY
Year agoJun 2025
€8.43B-11.4% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.4%——
1 year+7.9%——
3-year CAGR+3.3%——
5-year CAGR——
10-year CAGR——

Total Debt history

EUR · from the balance sheet

Latest · FY2025
8.09B EUR
Year-over-year change
+7.9%
4-year CAGR
+7.5%

Total Debt vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -11.4% is the 8th highest of 10, against a peer median of -3.0%.
  • Total debt amounts to 28.0% of total assets for PHG, versus a peer median of 27.9%.
PHG Competitors
Total Debt for PHG and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ABTAbbott LaboratoriesJun 2026$32.61B USD+142.7%-5.7%29.9%
MDTMedtronic plcJul 2026$28.15B USD-1.6%+4.7%30.2%
BSXBoston Scientific CorporationJun 2026$12.62B USD+5.0%+10.2%27.9%
GEHCGE HealthCare Technologies Inc.Jun 2026$10.09B USD-6.9%+5.0%27.1%
PHGKoninklijke Philips N.V.Jun 2026€7.47B EUR-11.4%+3.3%28.0%
SNNSmith & Nephew plcDec 2025$3.33B USD+0.2%+5.0%31.8%
RMDResMed Inc.Jun 2026$825.92M USD-3.0%-19.4%9.2%
LIVNLivaNova PLCSep 2026$347.9M USD-28.5%-6.6%12.8%
NPCENeuroPace, Inc.Mar 2026$70.46M USD-3.7%+0.5%71.2%
IRMDIRadimed CorporationMar 2026$0 USD-100.0%—0.0%
Peer median (excluding PHG) —-3.0%+2.6%27.9%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.3B1.17B1.87B2.4B2.79B
Short-term Investments2M11M3M2M0
Net Receivables4.29B4.65B4.25B3.67B3.53B
Inventory3.45B4.05B3.49B3.2B2.87B
Other Current Assets132M200M129M511M738M
Total Current Assets10.35B10.26B9.94B10.02B9.93B
Property, Plant & Equipment (Net)2.7B2.64B2.48B2.45B2.22B
Goodwill10.64B10.24B9.88B10.38B9.27B
Intangible Assets3.65B3.53B3.19B2.98B2.57B
Long-term Investments1.06B1.2B1B889M852M
Tax Assets2.22B2.45B2.63B1.92B0
Other Non-current Assets355M381M287M332M2.1B
Total Non-current Assets20.61B20.43B19.47B18.95B17.01B
Total Assets30.96B30.69B29.41B28.98B26.94B
Account Payables1.87B1.97B1.92B1.83B1.93B
Short-term Debt53M95M123M224M1.15B
Tax Payables318M155M212M186M0
Deferred Revenue1.49B1.7B1.81B1.7B0
Other Current Liabilities1.39B1.95B1.93B2.19B2.82B
Total Current Liabilities7.45B7.93B8.29B8.14B7.51B
Long-term Debt4.77B6.17B6.1B6.19B6.93B
Deferred Tax Liabilities83M91M71M81M0
Deferred Revenue (Non-current)446M515M469M431M0
Other Non-current Liabilities2.77B1.85B1.56B1.23B1.51B
Total Non-current Liabilities9.04B9.47B9.06B8.79B8.45B
Total Liabilities16.49B17.41B17.35B16.93B15.96B
Common Stock177M178M183M188M193M
Retained Earnings9.34B6.83B5.4B3.65B3.58B
Accumulated OCI748M1.49B879M1.93B274M
Other Stockholders Equity01M(1M)00
Minority Interest36M34M33M37M32M
Total Equity14.48B13.28B12.06B12.04B10.99B
Total Debt6.05B7.34B7.29B7.49B8.09B
Net Debt3.74B6.17B5.42B5.09B5.29B

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.